|[February 18, 2014]
Vancive Medical Technologies™, DUKAL™ Sign Agreement for Distribution of Absorbent Wound Dressings in USA and Canada
CHICAGO --(Business Wire)--
Vancive Medical Technologies™ and DUKAL Corporation today announced an
agreement for the distribution of the Vancive BeneHold™ Absorbent Wound
Dressing range in the United States and Canada. The BeneHold range
includes the Thin Absorbent Wound Dressing, the Standard Hydrocolloid
Dressing and the Bordered Hydrocolloid Dressing with Odor Control.
"This agreement between Vancive Medical Technologies and DUKAL Corp.
brings together Vancive's unique technologies and know-how with DUKAL's
specialized sales team," said Howard Kelly, president and general
manager of Vancive. "DUKAL's products are already used in traditional
wound and skin care, and by adding the BeneHold Absorbent Wound Dressing
range, they significantly broaden the continuum of care within their
The BeneHold Absorbent Wound Dressings manage lightly to moderately
exuding chronic and acute wounds. Products in the BeneHold Absorbent
Wound Dressing portfolio are constructed of a self-adherent wound
contact layer and a smooth, water-resistant polyurethane top film that
acts as a barrier to external contaminants and bacteria. The dressings
exhibit superior fluid handling capacity, yet are thinner and more
conformable to enhance patient comfort.
The Thin Absorbent Dressings are based on Vancive's proprietary
technology, TASA™ (Thin Absorbent Skin Adhesive™). At only 0.1mm in
thickness, TASA has the capacity to manage fluid in excess of
traditional thin hydrocolloids. Furthermore, the dressings are
transparent and allow for site visibility up to 7 days. The Bordered
Hydrocolloid Dressing with Odor Control isformulated with organic,
non-cytotoxic cyclodextrins that capture odor molecules to help increase
"Not only does this new agreement between DUKAL Corp. and Vancive
Medical Technologies benefit the two companies through the use of one
cohesive operational system and go-to-market strategy, it also extends
those efficiencies throughout the healthcare supply system," said DUKAL
President Gerry LoDuca. "This new alliance means our customers can now
secure an even greater breadth of products through a single provider."
BeneHold™ and TASA™ (Thin Absorbent Skin Adhesive™) are trademarks of
Avery Dennison Corporation.
About Vancive Medical Technologies
Vancive Medical Technologies makes inspired advances that lead to
intelligent results. The business uses the most advanced adhesive and
material technologies to create products that make healthcare easier for
everyone. Vancive Medical Technologies is an Avery Dennison business
headquartered in Chicago, Illinois. To learn more about Vancive Medical
Technologies, visit www.vancive.averydennison.com.
About Avery Dennison
Avery Dennison (NYSE:AVY) is a global leader in labeling and packaging
materials and solutions. The company's applications and technologies are
an integral part of products used in every major market and industry.
With operations in more than 50 countries and 26,000 employees
worldwide, Avery Dennison serves customers with insights and innovations
that help make brands more inspiring and the world more intelligent.
Headquartered in Glendale, California, the company reported sales from
continuing operations of $6.1 billion in 2013. Learn more at www.averydennison.com.
About Dukal Corporation
Established in 1991, DUKAL Corporation (www.dukal.com)
is a privately held supplier of medical, health and wellness products.
The company employs many strategic manufacturing partnerships focused on
high quality to provide best in class products and supply chain
solutions to its customers. DUKAL Corp. products are used in hospitals,
physician practices, home care agencies, nursing homes and dental
offices across the U.S. and Europe, as well as by veterinary practices
and animal hospitals, emergency medical services and public safety
providers, clinical laboratories and industrial sites.
[ Back To Technology News's Homepage ]